SCHEMBL30573073

SCHEMBL30573073

Cc1cc(C(C)(C)C(F)(F)F)c(Cl)c(F)c1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26606878 1.00 — —
SCHEMBL26607328 0.87 LPL (0.31) —
SCHEMBL26607099 0.77 LPL (0.33) —
SCHEMBL26601922 0.76 LPL (0.33) —
SCHEMBL26601739 0.75 — —
SCHEMBL30572991 0.75 — —
SCHEMBL26607090 0.73 LPL (0.31) —
SCHEMBL30573068 0.73 LPL (0.31) —
SCHEMBL26601768 0.73 — —
SCHEMBL30573058 0.70 CYP2C9 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4511114-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 — — EP disclosed
WO-2023205778-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback